What a half-life is#
A compound's elimination half-life is the time it takes for the amount in the body (measured in blood plasma) to fall by half. Most drugs and peptides follow first-order elimination: the body removes a fixed fraction of what is present per unit of time, not a fixed amount. When there is a lot in the body, a lot leaves; when there is little, little leaves. That is why the curve in the calculator falls steeply at first and then flattens, and why the time to lose half stays the same whatever the starting amount.
In numbers: after each half-life, half of what was there remains.
Amount left = starting amount × (1/2)^(time ÷ half-life)
A few compounds do not behave this way. When the body's clearance route is saturated, it removes a roughly fixed amount per hour instead (zero-order or non-linear kinetics; alcohol is the textbook example), and a single half-life no longer describes it.
The five half-lives rule#
Because each half-life removes half of what is left, the amount cleared climbs quickly and then creeps toward 100%:
| Half-lives passed | Cleared | Still in the body |
|---|---|---|
| 1 | 50% | 50% |
| 2 | 75% | 25% |
| 3 | 87.5% | 12.5% |
| 4 | 93.75% | 6.25% |
| 5 | 96.9% | 3.1% |
Pharmacology texts treat a compound as effectively eliminated after about 4 to 5 half-lives, when 94% to 97% is gone. The calculator draws its "cleared" line at 97%, which is 5.06 half-lives after the last dose. For a compound with a 7-day half-life that is about 35 days; for one with a 2-hour half-life, about 10 hours.
Steady state: why repeated doses build up and then level off#
When a new dose arrives before the last one has cleared, the two add together, so levels climb with each dose. They do not climb forever. Because elimination is a fraction of what is present, a higher level means more leaves between doses, and eventually the amount leaving between two doses equals one dose. That balance is steady state (the plateau in the chart).
Two numbers describe it.
How high the plateau is#
At steady state the peak is a multiple of a single dose, called the accumulation ratio:
Accumulation ratio = 1 ÷ (1 − (1/2)^(interval ÷ half-life))
The bottom of that fraction is simply the share of the body's amount that leaves during one dosing interval. Dosing once per half-life (a weekly dose of a compound with a 7-day half-life) gives 1 ÷ (1 − 1/2) = 2: the plateau peak is about twice a single dose. Dosing every two half-lives gives 1 ÷ (1 − 1/4) ≈ 1.33. Dosing much more often than the half-life gives a much larger multiple.
How long it takes to get there#
About 4 to 5 half-lives, whatever the dose or the interval. A bigger dose raises the plateau, and so does a shorter interval, but neither changes the time it takes to reach it, because that time is set only by how fast the body clears the compound. The calculator marks the day the average is within 3% of its plateau (about 5 half-lives from the first dose) and the day it reaches 90% (about 3.3 half-lives).
That is why a once-weekly compound with a half-life of about a week takes roughly a month to level off, while a compound with a half-life of minutes reaches its plateau in about an hour.
What this model leaves out#
The calculator uses the simplest model that captures build-up and clearance: one compartment, an instant dose, first-order elimination. Real pharmacokinetics is messier, so treat the chart as an illustration of the half-life's effect, not a prediction of anyone's blood levels:
- The absorption phase. An injection under the skin or a tablet is absorbed over hours or days, so the real peak arrives later and sits lower than the instant spike drawn here.
- Depots and long-acting forms. When absorption from the injection site is slower than elimination, the slow release, not the half-life, can set how long levels last.
- Active metabolites. Some compounds are broken down into products that are themselves active and have half-lives of their own.
- Non-linear kinetics. At high amounts some clearance routes saturate, and the half-life lengthens.
- Individual variation. Kidney and liver function, body size, age and other drugs all shift a half-life. A published figure is an average from a specific study group and route.
- Half-life is not effect duration. How long a compound stays measurable in plasma and how long any effect lasts are separate questions.
Half-lives of the compounds in the calculator#
Each figure below is a human plasma elimination half-life from a published study or an FDA label, with the route it was measured after. They run from VIP at about 1 minute to Testosterone Undecanoate at about 33.9 days. The "~97% gone" column is about 5 half-lives: how long after a single dose roughly 97% of it has left the body. Try it opens the calculator on that compound; Prices goes to its live vendor comparison.
A half-life depends on the route and the study population, so the same compound can show a different figure in another paper. Where a source gives a range, it is shown next to the typical value.
Not listed? Enter any half-life#
The compound list only holds compounds with a published, cited human half-life. For anything else, choose Custom half-life in the compound picker and type the half-life by hand, in minutes, hours or days. The maths does not depend on which compound it is, so the build-up, the steady-state day and the clearance time work the same way for any substance with first-order elimination.
To turn a vial into a measured volume, the reconstitution calculator does the water and syringe-unit arithmetic, and the guide to reconstituting peptides covers the steps. For more on individual compounds, see the retatrutide guide, the tirzepatide guide, the retatrutide vs tirzepatide comparison and the tesamorelin guide.
Frequently asked questions
What is a half-life?
The time it takes for the amount of a compound in the body to fall by half. With first-order elimination it is the same at any level: a 7-day half-life halves the amount every 7 days, whether the starting amount was large or small.
How many half-lives until a compound is gone?
About 4 to 5. After 4 half-lives about 94% has been cleared, and after 5 about 97%, which pharmacology texts treat as effectively eliminated. Very small amounts can remain measurable for longer.
What is steady state, and when is it reached?
Steady state is the plateau that repeated, regular doses settle at, when the amount cleared between doses equals the amount added by each dose. It takes about 4 to 5 half-lives from the first dose to get there.
Why does a once-weekly compound build up?
Because a week is not long enough for it to clear. With a half-life of about a week, half of each dose is still present when the next one arrives, so levels climb over several weeks until the plateau, where the peak is about twice a single dose.
Does a bigger dose change the half-life?
Not for compounds with first-order elimination: the half-life is a property of how the body clears the compound, so a bigger dose gives proportionally higher levels that fall at the same rate. The exception is non-linear kinetics, where a saturated clearance route makes the half-life longer at high amounts.
Does dosing more often get to steady state faster?
No. A shorter interval raises the plateau, but the time to reach it is still about 4 to 5 half-lives. Only the half-life sets that time.
Why is my compound not listed?
The list only includes compounds with a cited human plasma half-life. Many research peptides have none published, or only animal data, and we do not guess. You can still model one with the Custom half-life option if you have a figure from a source you trust.
Is this medical advice?
No. The calculator and this page are an educational model of first-order pharmacokinetics for research use. They are not a dosing guide, they do not predict anyone's blood levels, and they are not a recommendation to use any compound.
Comparing prices#
Half-life figures say nothing about quality or cost. To compare live prices, cost per mg and certificates of analysis, open any compound's Prices link in the table. Peptide Supply Co. is our recommended vendor; current prices for semaglutide, tirzepatide and retatrutide:
Sources
Each compound's half-life is cited in its own row of the reference table above.